Pathways to Entrepreneurship: Christoph Westphal, MD, PhD
Exciting opportunities bridge academia and entrepreneurship; hear alumni discuss their individual journeys from training to careers in industry. Speakers will offer unique perspectives on how a solid educational and research foundation can act as a springboard to making global impact in the public sector.
Companies founded by Dr. Westphal have invented important drugs, including the largest-selling heparin in the US, and several experimental medicines: for cystic fibrosis (phase 3), for currently incurable cancers (phase 2), and for serious inflammatory disorders (phase 2). In addition, these companies have created substantial shareholder value and aggregate market capitalizations (sustained) of over $8 billion.
- Co-founder, Partner: Longwood Fund
- Co-founder, CEO and Chairman: FlexPharma
- Co-founder, former CEO, Executive Chairman: Verastem
- Co-founder: Alnara Pharmaceuticals (acquired by Eli Lilly)
- Co-founder, Board of Directors: OvaScience
- Co-founder, former CEO: Sirtris (acquired by GSK)
- Co-founder, Former CEO: Alnylam Pharmaceuticals, Acceleron Pharmaceuticals and Momenta Pharmaceuticals
Dr. Westphal serves on the Board of Fellows of Harvard Medical School, and the Board of Overseers of the Boston Symphony Orchestra. He earned his M.D. from Harvard Medical School and Ph.D. in genetics from Harvard University and he graduated with a B.A. summa cum laude and Phi Beta Kappa from Columbia University. Dr. Westphal has been the lead or senior author on several patent applications and scientific papers in leading journals such as Cell, Nature and Nature Genetics. Dr. Westphal has been featured in the media, including on ‘60 Minutes’, CNN, an ABC News Special hosted by Barbara Walters, and as the subject of a Fortune cover article.